In severe cases of AD, the only clinically available pharmacological agent is a chemical known as memantine that works via blocking the excitatory neurotransmitter glutamate [15], which can be used alone or in combination with the AChE inhibitors [16]. Here, ACHE is linked to Alzheimer disease.